Capricor Therapeutics
CAPR
CAPR
29 hedge funds and large institutions have $8.95M invested in Capricor Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.06% more ownership
Funds ownership: 9.61% → 10.67% (+1.1%)
0% more call options, than puts
Call options by funds: $1.04M | Put options by funds: $1.04M
Holders
29
Holding in Top 10
–
Calls
$1.04M
Puts
$1.04M
Top Buyers
| 1 | +$732K | |
| 2 | +$186K | |
| 3 | +$180K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$75K |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$64K |
Top Sellers
| 1 | -$193K | |
| 2 | -$92.3K | |
| 3 | -$72.8K | |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
-$67K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$24.8K |